The geographical segmentation of the Oculodentodigital Syndrome Market region reveals a clear dominance by developed economies, specifically North America and Western Europe, a characteristic typical of markets for ultra-rare genetic disorders. The supremacy of these regions is attributable to several crucial factors: a highly advanced healthcare infrastructure capable of supporting...